Getting the Incentives Right: The Health Impact Fund A Concrete Contribution to Global Justice and an Innovation in Global Health

This point is especially obvious in regard to the current international system for encouraging pharmaceutical innovation, whose incentives are only tenuously related to health outcomes. This system is unsustainable as even the wealthiest countries cannot afford skyrocketing health care costs forever. There are huge collective gains waiting to be realized through reform of how we reward the development of new medicines.